Sort
64,565 grants matching “drug discovery”
Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis
$1,000,000Michelle M. Butler · Microbiotix, Inc · R44 · FY2020 · AI
Collaborative Research: EPiQC: Enabling Practical-Scale Quantum Computation
$1,000,000Kenneth R Brown · Duke University · · FY2018 · CSE
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · R44 · FY2014 · AI
Program 1: Therapeutic Development Program (TDP)
$1,000,000William R. Montfort · University Of Arizona · P30 · FY2020 · CA
Therapeutic Antibodies for CMV
$1,000,000William Robert Usinger · Trellis Bioscience, Inc. · R44 · FY2013 · AI
Narrow-spectrum Agents Acting against Helicobacter pylori
$1,000,000Kenneth Coleman · Arietis · R44 · FY2015 · AI
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · R44 · FY2015 · AI
High-Throughput Identification of BoNT Inhibitors
$1,000,000Scripps Research Institute · R01 · FY2005 · AI
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment
$1,000,000Anthony D Saleh · Mirecule, Inc. · U44 · FY2021 · CA
NIRT: Hierarchical Bionanomanufacturing
$1,000,000Robert L Clark · Duke University · · FY2006 · ENG
NQVL:QSTD:Pilot: Quantum Computing Applications of Photonics (QCAP)
$1,000,000Marek Osinski · University Of New Mexico · · FY2024 · MPS
Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool
$1,000,000Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2022 · AI
Identifying chemical probes against all essential genes
$1,000,000Stanford University · R01 · FY2004 · HG
Optimization of novel pyranopyridine efflux pump inhibitors
$1,000,000Timothy J Opperman · Microbiotix, Inc · R44 · FY2021 · AI
Multispray Technology for Studying Biomolecular Interactions
$1,000,000Daojing Wang · Newomics, Inc · R44 · FY2025 · GM
SBIR Phase II: Proteome Epitope Tags-Based Antibody Arrays for High-Throughput, Proteome-Wide Kinase Pathway Profiling
$1,000,000Neal F Gordon · Epitome Biosystems, Inc. · · FY2005 · TIP
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
$1,000,000Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2023 · AI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)
$1,000,000David H Haussler · University Of California Santa Cruz · U24 · FY2009 · CA
Restoring Beta-lactam efficacy against methicillin-resistant Staphylococci
$1,000,000Terry Roemer · Prokaryotics, Inc. · R44 · FY2020 · AI
NQVL:QSTD:Pilot: Quantum Blueprint: Optimizing Analog Pathways in Diverse Scientific Realms (Q-BLUE)
$1,000,000Mark S Gordon · Iowa State University · · FY2024 · MPS
EXTRA RES FACIL: FUNGI, GENOMICS, PROTEOMICS, DRUG DISCOVERY, BIOINFORMATICS
$1,000,000Albert Einstein Col Of Med Yeshiva Univ · C06 · FY2005 · RR
Derivation of human pluripotent stem cells using small molecules
$1,000,000Yanhong Shi · Beckman Research Institute/City Of Hope · RC1 · FY2010 · NS
Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency
$1,000,000James F Kronauge · Hesperos, Llc · U44 · FY2024 · TR
DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER
$1,000,000Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2017 · CA
Assigning mode of action to phenotypically discovered anticancer leads.
$1,000,000Sergei S Makarov · Attagene, Inc. · R44 · FY2023 · CA